TY - JOUR
T1 - A new era for hemophilia B treatment
AU - Taylor, Jason A.
AU - Kruse-Jarres, Rebecca
PY - 2016/4/7
Y1 - 2016/4/7
N2 - In this issue of Blood, Santagostino et al, in their phase 3 study, demonstrate efficacy and safety of recombinant fusion protein linking coagulation factor IX (FIX) with albumin (rIX-FP) which, along with the other 2 extended half-life FIX products, heralds a new era for the treatment of hemophilia B.
AB - In this issue of Blood, Santagostino et al, in their phase 3 study, demonstrate efficacy and safety of recombinant fusion protein linking coagulation factor IX (FIX) with albumin (rIX-FP) which, along with the other 2 extended half-life FIX products, heralds a new era for the treatment of hemophilia B.
UR - http://www.scopus.com/inward/record.url?scp=84963632274&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84963632274&partnerID=8YFLogxK
U2 - 10.1182/blood-2016-02-694869
DO - 10.1182/blood-2016-02-694869
M3 - Article
C2 - 27056991
AN - SCOPUS:84963632274
SN - 0006-4971
VL - 127
SP - 1734
EP - 1736
JO - Blood
JF - Blood
IS - 14
ER -